Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.450
-0.120 (-4.67%)
At close: Jul 19, 2024, 12:00 AM
2.470
+0.020 (0.82%)
Pre-market: Jul 22, 2024, 8:54 AM EDT
Vivos Therapeutics Employees
As of December 31, 2023, Vivos Therapeutics had 123 total employees, including 114 full-time and 9 part-time employees. The number of employees decreased by 40 or -24.54% compared to the previous year.
Employees
123
Change (1Y)
-40
Growth (1Y)
-24.54%
Revenue / Employee
$108,642
Profits / Employee
-$127,179
Market Cap
8.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 123 | -40 | -24.54% |
Dec 31, 2022 | 163 | -4 | -2.40% |
Dec 31, 2021 | 167 | 69 | 70.41% |
Dec 31, 2020 | 98 | 14 | 16.67% |
Dec 31, 2019 | 84 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Syra Health | 162 |
iCoreConnect | 70 |
Molecular Templates | 62 |
Organovo Holdings | 20 |
Kineta | 13 |
NLS Pharmaceutics AG | 7 |
Virpax Pharmaceuticals | 7 |
GlucoTrack | 6 |
VVOS News
- 25 days ago - Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model - GlobeNewsWire
- 5 weeks ago - Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance - GlobeNewsWire
- 2 months ago - Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 2 months ago - Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call - GlobeNewsWire
- 3 months ago - Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement - GlobeNewsWire
- 4 months ago - Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 months ago - Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call - GlobeNewsWire
- 5 months ago - Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities - GlobeNewsWire